Armata Pharmaceuticals (ARMP) Enterprise Value (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.28% |
| Dec 31, 2025 | 41.30% |
| Sep 30, 2025 | -244.19% |
| Jun 30, 2025 | 63.21% |
| Mar 31, 2025 | -25.80% |
| Dec 31, 2024 | 45.80% |
| Sep 30, 2024 | 35.08% |
| Jun 30, 2024 | 30.26% |
| Mar 31, 2024 | -179.97% |
| Dec 31, 2023 | 43.56% |
| Sep 30, 2023 | -92.34% |
| Jun 30, 2023 | 50.39% |
| Mar 31, 2023 | -69.04% |
| Dec 31, 2022 | 41.49% |
| Sep 30, 2022 | 31.36% |
| Jun 30, 2022 | 20.32% |
| Mar 31, 2022 | -351.09% |
| Dec 31, 2021 | 14.81% |
| Sep 30, 2021 | 31.14% |
| Jun 30, 2021 | 21.91% |
| Mar 31, 2021 | -132.72% |
| Dec 31, 2020 | 39.26% |
| Sep 30, 2020 | 19.72% |
| Jun 30, 2020 | 18.27% |
| Mar 31, 2020 | -301.28% |
| Dec 31, 2019 | 30.58% |
| Sep 30, 2019 | 34.13% |
| Jun 30, 2019 | -114.09% |
| Mar 31, 2019 | 36.23% |
| Dec 31, 2018 | 27.85% |
| Sep 30, 2018 | 13.17% |
| Jun 30, 2018 | -87.96% |
| Mar 31, 2018 | -59.90% |
| Dec 31, 2017 | 33.57% |
| Sep 30, 2017 | 13.80% |
| Jun 30, 2017 | -306.99% |
| Mar 31, 2017 | 57.09% |
| Dec 31, 2016 | -29.37% |
| Sep 30, 2016 | 44.47% |
| Jun 30, 2016 | -15.73% |